Tetrault Lynn A.

SEC CIK: 0001645512

SEC filings (opens in a new tab)

In the past year, 3 open-market sale filings worth $3.83M and no purchases.

Current role at each company

ALMS Alumis Inc.Directoras of Jul 2, 2026
RYTM Rhythm Pharmaceuticals, Inc.Directoras of Jun 25, 2026
NEO Neogenomics IncDirectoras of Jun 17, 2026
SLRN ACELYRIN, Inc.Directoras of May 23, 2025

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $3.83M; 3 filings
Net: −$3.83M; Bought minus sold
Companies: 2; With open-market trades

Trades

Every Form 4 that lists Tetrault Lynn A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

RYTM Rhythm Pharmaceuticals, Inc.

Director4 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jun 24, 2026 (view filing)	Jun 22	2 days	Tetrault Lynn A.Director	SSale	−37.0K	$100.32	−$3.71M	−84.1%7.00K after	10b5-1
Sep 11, 2024 (view filing)	Sep 9-10	2 days	Tetrault Lynn A.Director	SSale	−20.7K	$49.71	−$1.03M	−87.3%3.00K after	4 lots10b5-1
Aug 28, 2024 (view filing)	Aug 26	2 days	Tetrault Lynn A.Director	SSale	−4.30K	$50.01	−$215.0K	−58.9%3.00K after	10b5-1
Aug 14, 2024 (view filing)	Aug 12	2 days	Tetrault Lynn A.Director	SSale	−10.0K	$44.65	−$446.5K	−76.9%3.00K after	2 lots10b5-1

NEO Neogenomics Inc